ERA-话题@MedSci

#ERA#

425篇内容 | 3132人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738781, encodeId=9f611e387810a, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Laterality：跟爱人接吻时，你的头转向了哪一侧？, objectType=article, longId=63280, objectId=7b6e6328024, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b6e6328024, replyNumber=0, likeNumber=76, createdTime=2016-05-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b6e6328024, moduleTitle=Laterality：跟爱人接吻时，你的头转向了哪一侧？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b6e6328024)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738778, encodeId=2ceb1e3877808, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=PLoS ONE：非酒精性脂肪肝中年患者易发生房颤（OPERA研究）, objectType=article, longId=59328, objectId=9bdc5932878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bdc5932878, replyNumber=0, likeNumber=73, createdTime=2016-08-03, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bdc5932878, moduleTitle=PLoS ONE：非酒精性脂肪肝中年患者易发生房颤（OPERA研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bdc5932878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738774, encodeId=c8721e387748b, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy.：阿夫唑嗪针对远端尿道结石可改善结石消散率和时间, objectType=article, longId=51287, objectId=58205128efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58205128efa, replyNumber=0, likeNumber=47, createdTime=2015-08-24, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58205128efa, moduleTitle=Pharmacotherapy.：阿夫唑嗪针对远端尿道结石可改善结石消散率和时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58205128efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738777, encodeId=32fa1e38777bf, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranos：革命性验血技术在质疑声中前行, objectType=article, longId=53646, objectId=d088536467a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d088536467a, replyNumber=0, likeNumber=57, createdTime=2016-02-09, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d088536467a, moduleTitle=Theranos：革命性验血技术在质疑声中前行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d088536467a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738780, encodeId=8e761e38780ae, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=华西医院日间手术快速康复（ERAS）规范, objectType=article, longId=65478, objectId=6dc3654e802, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6dc3654e802, replyNumber=0, likeNumber=72, createdTime=2016-09-23, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6dc3654e802, moduleTitle=华西医院日间手术快速康复（ERAS）规范, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6dc3654e802)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738779, encodeId=7a661e38779e0, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Stroke：急性脑出血患者控制血糖对预后效果好(INTERACT2研究), objectType=article, longId=62707, objectId=245b62e071f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245b62e071f, replyNumber=0, likeNumber=62, createdTime=2016-08-02, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245b62e071f, moduleTitle=Stroke：急性脑出血患者控制血糖对预后效果好(INTERACT2研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245b62e071f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738772, encodeId=ebe71e38772d7, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=哪里想瘦打哪里！FDA批准Kythera注射药物上市在即, objectType=article, longId=47989, objectId=23e84e98996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23e84e98996, replyNumber=0, likeNumber=51, createdTime=2015-05-30, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23e84e98996, moduleTitle=哪里想瘦打哪里！FDA批准Kythera注射药物上市在即, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23e84e98996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738776, encodeId=dabd1e3877675, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=英国发明一款神器Chimaera，可精准定位脑部神经, objectType=article, longId=53487, objectId=ec145348eca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec145348eca, replyNumber=0, likeNumber=54, createdTime=2015-12-29, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec145348eca, moduleTitle=英国发明一款神器Chimaera，可精准定位脑部神经, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec145348eca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738775, encodeId=feab1e387759c, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=美国Theranos公司将用几滴血颠覆体检方式, objectType=article, longId=52952, objectId=70d052952c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70d052952c1, replyNumber=0, likeNumber=81, createdTime=2015-07-20, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70d052952c1, moduleTitle=美国Theranos公司将用几滴血颠覆体检方式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70d052952c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738761, encodeId=e1de1e38761b4, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Lancet Diab & Endo：磷脂饱和脂肪酸与2型糖尿病密切相关（EPIC-InterAct研究）, objectType=article, longId=41432, objectId=b723414321c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b723414321c, replyNumber=0, likeNumber=76, createdTime=2015-03-20, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b723414321c, moduleTitle=Lancet Diab & Endo：磷脂饱和脂肪酸与2型糖尿病密切相关（EPIC-InterAct研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b723414321c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738771, encodeId=1d921e38771a6, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Gene Therapy：我国科学家利用CRISPR破坏乙肝病毒, objectType=article, longId=47190, objectId=29364e190cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29364e190cd, replyNumber=0, likeNumber=68, createdTime=2015-05-29, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29364e190cd, moduleTitle=Gene Therapy：我国科学家利用CRISPR破坏乙肝病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29364e190cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738765, encodeId=28a41e38765e7, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器, objectType=article, longId=42645, objectId=aaf742645e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf742645e0, replyNumber=0, likeNumber=70, createdTime=2015-04-29, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf742645e0, moduleTitle=Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf742645e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738766, encodeId=f5821e38766e1, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Puma生物科技宣布neratinib“积极”临床结果, objectType=article, longId=42661, objectId=a7b64266110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7b64266110, replyNumber=0, likeNumber=58, createdTime=2015-07-14, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7b64266110, moduleTitle=Puma生物科技宣布neratinib“积极”临床结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7b64266110)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738770, encodeId=b69b1e38770db, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=艾伯维丙肝新药Viekira + Exviera获欧洲药品委员会批准, objectType=article, longId=45691, objectId=02a245691ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02a245691ef, replyNumber=0, likeNumber=70, createdTime=2015-07-06, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02a245691ef, moduleTitle=艾伯维丙肝新药Viekira + Exviera获欧洲药品委员会批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02a245691ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738773, encodeId=b6791e3877366, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：普拉德-威利综合症患者使用抗精神病药物和体重之间的关系, objectType=article, longId=48822, objectId=54ff4882210, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54ff4882210, replyNumber=0, likeNumber=55, createdTime=2015-12-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54ff4882210, moduleTitle=Pharmacotherapy：普拉德-威利综合症患者使用抗精神病药物和体重之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54ff4882210)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738758, encodeId=20c81e3875826, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=ERA-EDTA 2014：依库珠单抗可改善非典型溶血尿毒症综合征患者肾功能, objectType=article, longId=38177, objectId=564d381e7a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=564d381e7a4, replyNumber=0, likeNumber=66, createdTime=2015-02-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=564d381e7a4, moduleTitle=ERA-EDTA 2014：依库珠单抗可改善非典型溶血尿毒症综合征患者肾功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=564d381e7a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738762, encodeId=479f1e387628a, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Lancet Diab & Endo：预测2型糖尿病的无创风险评分评价 (EPIC-InterAct研究), objectType=article, longId=41433, objectId=68114143348, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68114143348, replyNumber=0, likeNumber=57, createdTime=2014-10-27, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68114143348, moduleTitle=Lancet Diab & Endo：预测2型糖尿病的无创风险评分评价 (EPIC-InterAct研究), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68114143348)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738757, encodeId=19c01e38757a7, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=GSK与Theravance携手开发新COPD药物, objectType=article, longId=38061, objectId=9318380617a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9318380617a, replyNumber=0, likeNumber=55, createdTime=2014-11-01, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9318380617a, moduleTitle=GSK与Theravance携手开发新COPD药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9318380617a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738768, encodeId=f3451e3876896, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=CAR-T疗法扩展：Unum Therapeutic招募一期临床病人, objectType=article, longId=43480, objectId=00244348054, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00244348054, replyNumber=0, likeNumber=65, createdTime=2015-09-27, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00244348054, moduleTitle=CAR-T疗法扩展：Unum Therapeutic招募一期临床病人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00244348054)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738754, encodeId=b3df1e38754ce, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Puma制药neratinib用于HER2阳性乳腺癌疗效优于罗氏赫赛汀, objectType=article, longId=33006, objectId=1aa333006b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1aa333006b4, replyNumber=0, likeNumber=63, createdTime=2015-02-16, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1aa333006b4, moduleTitle=Puma制药neratinib用于HER2阳性乳腺癌疗效优于罗氏赫赛汀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa333006b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#ERA#

Laterality：跟爱人接吻时，你的头转向了哪一侧？

2016-05-27

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

PLoS ONE：非酒精性脂肪肝中年患者易发生房颤（OPERA研究）

2016-08-03

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy.：阿夫唑嗪针对远端尿道结石可改善结石消散率和时间

2015-08-24

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranos：革命性验血技术在质疑声中前行

2016-02-09

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

华西医院日间手术快速康复（ERAS）规范

2016-09-23

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Stroke：急性脑出血患者控制血糖对预后效果好(INTERACT2研究)

2016-08-02

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

哪里想瘦打哪里！FDA批准Kythera注射药物上市在即

2015-05-30

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

英国发明一款神器Chimaera，可精准定位脑部神经

2015-12-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

美国Theranos公司将用几滴血颠覆体检方式

2015-07-20

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Lancet Diab & Endo：磷脂饱和脂肪酸与2型糖尿病密切相关（EPIC-InterAct研究）

2015-03-20

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Gene Therapy：我国科学家利用CRISPR破坏乙肝病毒

2015-05-29

柳叶一刀 (审核中...)

前往app查看评论内容

#ERA#

Mol Can Therap：实验性抗癌药物TAK-733或是新一代杀灭黑色素瘤的利器

2015-04-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Puma生物科技宣布neratinib“积极”临床结果

2015-07-14

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

艾伯维丙肝新药Viekira + Exviera获欧洲药品委员会批准

2015-07-06

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：普拉德-威利综合症患者使用抗精神病药物和体重之间的关系

2015-12-21

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

ERA-EDTA 2014：依库珠单抗可改善非典型溶血尿毒症综合征患者肾功能

2015-02-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Lancet Diab & Endo：预测2型糖尿病的无创风险评分评价 (EPIC-InterAct研究)

2014-10-27

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

GSK与Theravance携手开发新COPD药物

2014-11-01

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

CAR-T疗法扩展：Unum Therapeutic招募一期临床病人

2015-09-27

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Puma制药neratinib用于HER2阳性乳腺癌疗效优于罗氏赫赛汀

2015-02-16

科室
- - 订阅+
  - 更多科室
工具
服务